India's preferred Personal finance destination
Home Shares News Centre F&O Mutual Funds IPO Portfolio Commodity Loans Financial Planning Insurance About Us
Markets Companies Research Industries E-Mail Page
Wealth Tracker      Tax Corner NRI Centre Chat Masala Feedback

my Last 5 Scrips
Company BSE Price(Rs) % Chg
Dr. Redd 2647.00 2.28
Power Gr 198.00 5.32
Bharti A 335.00 1.43
Bajaj Au 3015.50 0.32
Coal Ind 243.80 2.33
Clear All Clear Last
Equity
NSE Live
Nifty Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
BSE Live
BSE30 Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Market Pulse
Leaders
Laggards
FII Activity
Mutual Fund Activity
Meetings
Results Watch
Results Calendar
Results Announced
IPO Watch
Company
Snapshots
Quotes
Charts
Financials
Recent News
Broker Research
Meetings
Research Tutorial
Discussion Forum
Research
Research Reports
News Watch
Sector Watch
Economy Watch
News-Lupin Limited
Lupin Limited
Sector:Pharmaceuticals Pharmaceuticals - Bulk Drugs
BSE:500257NSE:LUPINBloomberg:LPC@INReuters:LUPN.BO
Market Lot: 1Face Value: 2ISIN Demat: INE326A01037
QuotesSnapshotChartsFinancialsResearchRecent News
Peer GroupAGM/AMMF HoldingDiscussion ForumBSE/NSE NoticesBSE/NSE Deals

 
Corporate News
28-Feb-2019       Lupin launches generic Ranolazine extended-release tablets in US IRIS
25-Feb-2019       Lupin receives approval for Methylprednisolone tablets USP IRIS
15-Feb-2019       Lupin launches Clobazam oral suspension IRIS
12-Feb-2019       Lupin receives FDA approval for Fluoxetine Tablets IRIS
12-Feb-2019       Lupin launches Tadalafil Tablets IRIS
11-Feb-2019       Lupin receives 2 USFDA observations for Goa manufacturing facility IRIS
07-Feb-2019       Lupin receives USFDA approval for Tadalafil tablets USP IRIS
06-Feb-2019       Lupin launches Clomipramine Hydrochloride capsules USP IRIS
28-Jan-2019       USFDA completes inspection of Lupin's Pithampur Unit -2 (Indore) facility IRIS
21-Jan-2019       Lupin receives USFDA approval for Levothyroxine Sodium tablets IRIS
09-Jan-2019       Lupin gets European commission approval for NaMuscla IRIS
07-Jan-2019       Lupin gets USFDA approval for Lurasidone HCl tablets IRIS
01-Jan-2019       Lupin receives USFDA approval for Clobazam oral suspension IRIS
24-Dec-2018       Lupin, AbbVie ink pact to develop novel oncology drug IRIS
18-Dec-2018       Lupin receives approval from USFDA for Clobazam tablets IRIS
17-Dec-2018       Lupin receives tentative USFDA approval for Tadalafil tablets IRIS
11-Dec-2018       Lupin receives tentative USFDA approval for Apixaban tablets IRIS
10-Dec-2018       Lupin receives EIR from USFDA for Indore facility IRIS
05-Dec-2018       USFDA completes inspection of Lupin's Mandideep location IRIS
05-Dec-2018       Lupin launches generic Silodosin capsules in United States IRIS

 

 


Home | Shares | F&O | Mutual Funds | Loans | Insurance | News Centre
Wealth Tracker | Tax Corner | NRI Centre | Search in myiris | Advertise
All rights reserved. IRIS Business Services Limited
Disclaimer